TI
CRL icon

Tidal Investments’s Charles River Laboratories CRL Stock Holding History

Tidal Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
6,371
+1,334
+26% +$238K ﹤0.01% 1541
2026
Q1 		$869K Sell
5,037
-420
-8% -$77.9K ﹤0.01% 1550
2025
Q4 		$1.09M Sell
5,457
-4,105
-43% -$745K ﹤0.01% 1226
2025
Q3 		$1.5M Buy
9,562
+1,353
+16% +$215K ﹤0.01% 1028
2025
Q2 		$1.25M Sell
8,209
-20,162
-71% -$2.69M 0.01% 933
2025
Q1 		$4.27M Buy
28,371
+19,175
+209% +$3.21M 0.03% 439
2024
Q4 		$1.7M Buy
9,196
+744
+9% +$143K 0.01% 763
2024
Q3 		$1.66M Buy
8,452
+2,319
+38% +$482K 0.02% 746
2024
Q2 		$1.27M Buy
6,133
+836
+16% +$189K 0.02% 773
2024
Q1 		$1.44M Buy
5,297
+2,646
+100% +$632K 0.02% 704
2023
Q4 		$627K Buy
2,651
+1,072
+68% +$211K 0.01% 842
2023
Q3 		$309K Buy
1,579
+174
+12% +$35.7K 0.01% 1051
2023
Q2 		$295K Buy
1,405
+90
+7% +$17.9K 0.01% 1054
2023
Q1 		$265K Buy
1,315
+61
+5% +$13.8K 0.01% 1065
2022
Q4 		$273K Buy
1,254
+113
+10% +$24.7K 0.01% 893
2022
Q3 		$225K Buy
1,141
+52
+5% +$11.2K 0.01% 919
2022
Q2 		$233K Sell
1,089
-70
-6% -$17.1K 0.01% 929
2022
Q1 		$329K Buy
1,159
+152
+15% +$46.9K 0.01% 797
2021
Q4 		$379K Buy
1,007
+188
+23% +$73K 0.01% 697
2021
Q3 		$338K Buy
819
+244
+42% +$101K 0.01% 632
2021
Q2 		$213K Buy
+575
New +$192K 0.01% 679

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Tidal Investments's CRL Position: Q2 2026 in Review

Tidal Investments increased its Charles River Laboratories (CRL) stake by 26% in Q2 2026, buying an estimated $238K and bringing the position to 6,371 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Tidal Investments first reported a position in CRL in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.27M in Q1 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Tidal Investments held 6,371 shares of Charles River Laboratories worth $1.44M as of Q2 2026.
  • Tidal Investments bought 1,334 Charles River Laboratories shares in Q2 2026, an estimated $238K.
  • Charles River Laboratories made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1541 holding.
  • Tidal Investments first reported a position in Charles River Laboratories in Q2 2021 and has held it in 21 quarters since.
  • Tidal Investments's Charles River Laboratories position peaked at $4.27M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.